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Abstract: 
Background: In Pakistan, the death of the people is mostly affected due to malaria. In various parts of the world, 
there found variations in the incidence of malaria. On laboratory examination, anaemia, leucopenia and 
thrombocytopenia indicate malaria. Whereas, in the clinical checkup, headache, acute renal failure, joints pain, 
dizziness, hepatopathy, congenital malaria, chills and fever with rigours are some factors that mark the presence of 
malaria. 
Objective: This study was conducted on the patients of malaria in order to determine the frequency of 
thrombocytopenia and kinds of parasites found among patients of malaria. 
Materials and Methods: This research study was conducted in the timeframe of September 2017 to October 2018 at 
Services Hospital, Lahore. The people at the risk of having malaria were selected for this research. Malaria 
identification was made on the basis of laboratory parameters (thick and thin film), history and physical assessment. 
SPSS was used for data entry and assessment. 
Results: Total patients selected for this research study were 273 with malaria identification among 190 patients 
(69.6%). Falciparum malaria and Plasmodium Vivax effected 45 patients (23.7%) and 145 patients (76.3%) 
respectively. Falciparum species infected 33 (21.8%) patients, the species of vivax infected 118 (78.1%) patients and 
thrombocytopenia were observed in 151 (79.5%) patients out of 190 patients. 
Conclusion: Based on the outcomes, it is illustrated that Vivax and Falciparum malaria is found in most of the patients 
of the target area. Different frequency of thrombocytopenia was also present in the majority of the patients. 
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INTRODUCTION: 
All around the globe, the health of people is affected 
by malaria. There observed variation in the morbidity 
and rate of death due to malaria [1]. All over the world, 
300 – 500 million people suffered from malaria. The 
approximate occasion of malaria every year is 20 
million [2, 3]. Three percent of malaria patients are 
subjected to death [4]. According to an estimate, the 
incidence of malaria in Pakistan is 43% and still 
affecting a large number of people [5, 6]. Many 
haematological issues result from malaria. 
Thrombocytopenia and anaemia are among these 
issues [7, 8]. Altered consciousness, vomiting, 
splenomegaly, cough, congenital malaria, diarrhoea, 
seizures, acute renal failure, disseminated 
intravascular coagulation and jaundice with hepatic 
dysfunction are some other complexities that are 
associated with malaria [7 – 11]. In patients having 
malaria, the most commonly found haematological 
disorder is thrombocytopenia Splenic sequestration, 
raised IL-10 levels, immune-mediated lysis and 
dysgenesis are some contributing factors of 
thrombocytopenia [12]. The current study was 
conducted in a tertiary care hospital. Districts of 
Gujrat, Mandibahaudin and Jhelum were also included 
in our research. All the health services are available 
there. The aim of this research was to assess the 
frequency of thrombocytopenia and kinds of parasites 
found among the patients of malaria. 
 
PATIENTS AND METHODS: 
This research study was conducted in the timeframe of 
September 2017 to October 2018 at Services Hospital, 
Lahore. The age bracket for this research was from six 
months to twelve years. These patients were presented 
from outdoor, indoor and causality reception centres 
and were also suffering from headache, dizziness, 
body ache, joint pain, high fever, chills, sweating, 
rigours and chills. All the patients were checked. From 
all the patients, four-millilitre venous blood was taken 
in a particular bottle. To estimate the presence of 
thrombocytopenia, this ample blood was sent for 
Giemsa Staining (thick and thin films) and automated 
coulter analyzer. These patients were again examined 
if observed with low platelet numbers. According to 
the Memon et al. the thrombocytopenia was grouped 
[13]. 
Severe Thrombocytopenia: Less than 20,000 
Moderate Thrombocytopenia: Less than 50,000 to 
more than 20,000 
Mild Thrombocytopenia: Less than 150,000 to more 
than 50,000 
The patients, who were not willing to participate in the 
research and who were having a history of bleeding 
disorder, meningitis, pharyngitis, urinary tract 
infections and drugs (hemolytic agents, guanine) were 
not selected for this research. For the measurement of 
the level of thrombocytopenia and type of species, 
percentages and frequency were calculated. Detailed 
history and examination record were collected on the 
questionnaire. SPSS was used for data entry and 
assessment. 
 
RESULTS: 
Total patients enrolled in the research were 273. On 
Giemsa staining, malaria was not detected in 83 
patients (30.4%) and malaria was detected in 190 
patients (69.6). The number of males and females were 
93 (50.5%) and 94 (49.5%) respectively. From these 
patients, falciparum strain and Vivax strain were the 
cause of malaria in 45 (23.7%) and 145 (76.3%) cases; 
whereas, its occurrence was not reported in 39 
(20.5%). Mild-moderate and severe thrombocytopenia 
were found in 59 (39.1%), 91 (60.3%) and 1 (0.7%) 
cases respectively. Among patients having 
thrombopenia, falciparum malaria was observed in 33 
(21.8%) and Vivax strain in 118 (78.1%) cases 
(Table). In the patients suffered from Vivax strain, 
moderate thrombocytopenia was noticed in 71 
(60.16%) and mild thrombocytopenia was noticed in 
47 (39.8%) patients. 12 (36.3%) were having mild, 20 
(60.6%) were having moderate and 01 (3.03%) were 
having a severe degree of thrombocytopenia in the 
cases affected with falciparum. 
 
Table: Severity of Thrombocytopenia 
 
Thrombocytopenia Frequency Percentage 
Mild (<150000 - >50000 59 39.1 
Moderate (<50000 - > 20000) 91 60.3 
Severe (< 20000) 1 0.7 
Total 151 100 
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DISCUSSION: 
Diarrhoea, seizures, hepatopathy, cough, fever, 
abdominal discomfort, jaundice, altered 
consciousness, acute renal failure and congenital 
malaria are some factors that mark the identification of 
malaria [9 – 11]. The frequency of thrombocytopenia 
is different in different cases. Most of the infections 
are caused by falciparum and vivax. Malaria is 
identified if the number of platelets on the peripheral 
film is not normal [14]. Disseminated intravascular 
coagulation may mark the presence of 
thrombocytopenia or it can have hemorrhagic 
manifestation [15]. Intake of the platelet itself by the 
malaria parasite, sequestration, defective platelet 
surface, immune-mediated lysis and diagenesis are 
different theories that explain the establishment of 
thrombocytopenia [1, 14]. However, the exact 
development of thrombocytopenia is not known, 
according to the study of Casals C, it is observed that 
a smaller number of platelets is due to the high 
connection of IL10 [12]. When there is a reduction in 
the number of platelets, the level of thrombocytopenia 
is increased. It is needed for the production and 
multiplication of platelets. When malaria is in serious 
condition, the level of thrombopoietin is elevated. 
After the 14 – 21 days of treatment of malaria, its level 
becomes normal [1, 16]. Thrombocytopenia was 
noticed in 79.5% of malaria patients in our study. 
These outcomes are almost similar to the results of 
studies conducted by Jadhav 978%0, Shoaib (69.18%) 
and Uttra (72%) [1, 2, 14]. The prevalence of 
thrombocytopenia was 53% according to the study by 
Bashara. Moreover, 58% of the malaria patients had 
thrombocytopenia according to study organized by 
Shiraz [17, 18]. For the identification of malaria, 
detection of thrombocytopenia is an important factor. 
In children having falciparum malaria, the seriousness 
of disease can be checked through thrombocytopenia 
[19]. It is observed that moderate thrombocytopenia 
was present in 60.16% cases and mild in 39.8% cases 
among the cases infection with Plasmodium vivax. 
The results of studies conducted by Aggarwal, 
Metanat and Makkar are comparable with our results 
[21, 23]. It has been suggested that immune/non-
immune destruction of platelets and evolution of a new 
strain of vivax are the causes for thrombocytopenia in 
vivax infected cases. There is the requirement of many 
studies to point out of specific reason. 
 
CONCLUSION: 
It is concluded by the results that in this area of 
Pakistan, thrombocytopenia is present in high extent 
with infections of Plasmodium vivax. It is also noticed 
that the cases of vivax malaria are more frequent. 
Thrombocytopenia is an attribute of malaria and it 
should be expelled from any febrile illness. 
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